Molecularly Imprinted Nanoparticles towards MMP9 for Controlling Cardiac ECM after Myocardial Infarction: A Predictive Experimental-Computational Chemistry Investigation

The recent advances in nanotechnology are revolutionizing preventive and therapeutic approaches to treating cardiovascular diseases. Controlling the extracellular matrix metalloproteinase (MMP) activation and expression in the failing human left ventricular myocardium represents a significant therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Villano, Anthea, Barcaro, Giovanni, Monti, Susanna, Barbani, Niccoletta, Rizzo, Antonio, Rossin, Daniela, Rastaldo, Raffaella, Giachino, Claudia, Cristallini, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495980/
https://www.ncbi.nlm.nih.gov/pubmed/36140171
http://dx.doi.org/10.3390/biomedicines10092070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495980/
https://www.ncbi.nlm.nih.gov/pubmed/36140171
http://dx.doi.org/10.3390/biomedicines10092070

Ejemplares similares